Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician’s prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
This report contains market size and forecasts of Drugs for Malaria in Global, including the following market information:
Global Drugs for Malaria Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drugs for Malaria market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Aryl Aminoalcohol Compounds Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Malaria companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Malaria Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Malaria Market Segment Percentages, by Type, 2021 (%)
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Global Drugs for Malaria Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Malaria Market Segment Percentages, by Application, 2021 (%)
Prevention
Treatment
Others
Global Drugs for Malaria Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drugs for Malaria Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Malaria revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drugs for Malaria revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma

LEAVE A REPLY

Please enter your comment!
Please enter your name here